Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vistin Pharma Proxy Solicitation & Information Statement 2025

May 22, 2025

3782_dva_2025-05-22_688f2454-d4aa-4fe4-8a5e-7ee208846168.html

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

Disclosure of voting rights at AGM in Vistin Pharma ASA

Disclosure of voting rights at AGM in Vistin Pharma ASA

Oslo, Norway, 22 May 2025

In relation to the Annual General Meeting in Vistin Pharma ASA (OSE: VISTN), on

the 22th of May, the Company's Chair of the Board, Øyvin Brøymer, has received

open proxies to represent a total of 5 156 012 shares in the Company at the AGM,

corresponding to 11.63% of the total number of votes and shares in the Company.

Together with the 14 509 280 shares held by Øyvin Brøymer through Intertrade

Shipping AS, he will represent a total of 19 665 292 votes at the AGM,

corresponding to a total of 44,35% of the total number of shares and votes in

the Company. The proxies are only valid for the AGM and will lapse thereafter.